Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Enrichment of tumor-initiating breast cancer cells within a mammosphere-culture microdevice.

Saadin K, Burke JM, Patel NP, Zubajlo RE, White IM.

Biomed Microdevices. 2013 Aug;15(4):645-655. doi: 10.1007/s10544-013-9755-y.

PMID:
23515914
2.

[Influence factors on the formation of mammospheres from breast cancer stem cells].

Huang MZ, Zhang FC, Zhang YY.

Beijing Da Xue Xue Bao. 2008 Oct 18;40(5):500-4. Chinese.

3.

Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.

Wahler J, So JY, Cheng LC, Maehr H, Uskokovic M, Suh N.

J Steroid Biochem Mol Biol. 2015 Apr;148:148-55. doi: 10.1016/j.jsbmb.2014.10.016. Epub 2014 Oct 31.

4.

Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin.

Manuel Iglesias J, Beloqui I, Garcia-Garcia F, Leis O, Vazquez-Martin A, Eguiara A, Cufi S, Pavon A, Menendez JA, Dopazo J, Martin AG.

PLoS One. 2013 Oct 4;8(10):e77281. doi: 10.1371/journal.pone.0077281. eCollection 2013.

5.

Senescence evasion by MCF-7 human breast tumor-initiating cells.

Karimi-Busheri F, Rasouli-Nia A, Mackey JR, Weinfeld M.

Breast Cancer Res. 2010;12(3):R31. doi: 10.1186/bcr2583. Epub 2010 Jun 2.

6.

Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.

Rappa G, Lorico A.

Exp Cell Res. 2010 May 15;316(9):1576-86. doi: 10.1016/j.yexcr.2010.01.012. Epub 2010 Jan 11.

7.

Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.

Zhang F, Song C, Ma Y, Tang L, Xu Y, Wang H.

Int J Mol Med. 2011 Sep;28(3):365-71. doi: 10.3892/ijmm.2011.700. Epub 2011 May 13.

PMID:
21573501
8.

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.

Phillips TM, McBride WH, Pajonk F.

J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85.

PMID:
17179479
9.

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.

Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP, White BA.

Breast Cancer Res Treat. 2012 Feb;132(1):75-85. doi: 10.1007/s10549-011-1534-y. Epub 2011 May 7.

PMID:
21553120
10.

High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.

Farnie G, Sotgia F, Lisanti MP.

Oncotarget. 2015 Oct 13;6(31):30472-86. doi: 10.18632/oncotarget.5401.

11.

AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity.

Brantley E, Callero MA, Berardi DE, Campbell P, Rowland L, Zylstra D, Amis L, Yee M, Simian M, Todaro L, Loaiza-Perez AI, Soto U.

Cancer Lett. 2016 Jun 28;376(1):53-61. doi: 10.1016/j.canlet.2016.03.025. Epub 2016 Mar 17.

PMID:
26996297
12.

MicroRNA expression analysis of mammospheres cultured from human breast cancers.

Feifei N, Mingzhi Z, Yanyun Z, Huanle Z, Fang R, Mingzhu H, Mingzhi C, Yafei S, Fengchun Z.

J Cancer Res Clin Oncol. 2012 Nov;138(11):1937-44. doi: 10.1007/s00432-012-1272-5. Epub 2012 Jul 3.

PMID:
22752669
13.

ABCG2 is a potential marker of tumor-initiating cells in breast cancer.

Sicchieri RD, da Silveira WA, Mandarano LR, de Oliveira TM, Carrara HH, Muglia VF, de Andrade JM, Tiezzi DG.

Tumour Biol. 2015 Dec;36(12):9233-43. doi: 10.1007/s13277-015-3647-0. Epub 2015 Jun 20.

PMID:
26091795
14.

A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype.

Wolf J, Dewi DL, Fredebohm J, Müller-Decker K, Flechtenmacher C, Hoheisel JD, Boettcher M.

Breast Cancer Res. 2013 Nov 14;15(6):R109. doi: 10.1186/bcr3576.

15.

CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.

Ji P, Zhang Y, Wang SJ, Ge HL, Zhao GP, Xu YC, Wang Y.

Oncol Rep. 2016 Jun;35(6):3293-302. doi: 10.3892/or.2016.4739. Epub 2016 Apr 11.

PMID:
27109463
16.

Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.

Peleg R, Romzova M, Kogan-Zviagin I, Apte RN, Priel E.

BMC Cancer. 2014 Dec 3;14:910. doi: 10.1186/1471-2407-14-910.

17.

Impact of cell dissociation on identification of breast cancer stem cells.

Quan Y, Yan Y, Wang X, Fu Q, Wang W, Wu J, Yang G, Ren J, Wang Y.

Cancer Biomark. 2012-2013;12(3):125-33. doi: 10.3233/CBM-130300.

PMID:
23481571
18.

Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.

Prud'homme GJ, Glinka Y, Toulina A, Ace O, Subramaniam V, Jothy S.

PLoS One. 2010 Nov 3;5(11):e13831. doi: 10.1371/journal.pone.0013831.

19.

Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.

Kok M, Koornstra RH, Margarido TC, Fles R, Armstrong NJ, Linn SC, Van't Veer LJ, Weigelt B.

J Pathol. 2009 Jul;218(3):316-26. doi: 10.1002/path.2544.

PMID:
19353633
20.

Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.

Giordano C, Chemi F, Panza S, Barone I, Bonofiglio D, Lanzino M, Cordella A, Campana A, Hashim A, Rizza P, Leggio A, Győrffy B, Simões BM, Clarke RB, Weisz A, Catalano S, Andò S.

Oncotarget. 2016 Jan 12;7(2):1262-75. doi: 10.18632/oncotarget.6014.

Supplemental Content

Support Center